We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+16.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.82B
AUM Growth
+$1.31B
Cap. Flow
+$158M
Cap. Flow %
2.03%
Top 10 Hldgs %
19.27%
Holding
869
New
65
Increased
350
Reduced
240
Closed
81

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$43.7M
2
BMY icon
Bristol-Myers Squibb
BMY
+$30.4M
3
GILD icon
Gilead Sciences
GILD
+$28.3M
4
BIIB icon
Biogen
BIIB
+$26.7M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$25.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$75.2M
2
LOXO
Loxo Oncology, Inc
LOXO
+$28.1M
3
DHR icon
Danaher
DHR
+$27.9M
4
A icon
Agilent Technologies
A
+$26.4M
5
MKC icon
McCormick & Company Non-Voting
MKC
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 33.36%
2 Technology 15.96%
3 Financials 11.25%
4 Consumer Discretionary 8.98%
5 Communication Services 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMBA icon
176
Ambarella
AMBA
$2.99B
$10.8M 0.14%
249,983
-1,497
-0.6% -$59.2K
CTXS
177
DELISTED
Citrix Systems Inc
CTXS
$10.6M 0.14%
96,948
-96,186
-50% -$9.97M
UPS icon
178
United Parcel Service
UPS
$97.6B
$10.5M 0.13%
94,228
-105,797
-53% -$11.2M
GE icon
179
GE Aerospace
GE
$367B
$10.3M 0.13%
207,555
-247,825
-54% -$11.7M
PARA
180
DELISTED
Paramount Global Class B
PARA
$10.3M 0.13%
217,405
+83,222
+62% +$4.05M
APLS
181
DELISTED
Apellis Pharmaceuticals
APLS
$10.3M 0.13%
527,700
– –
SPLK
182
DELISTED
Splunk Inc
SPLK
$10.2M 0.13%
81,776
-46,446
-36% -$5.8M
CHTR icon
183
Charter Communications
CHTR
$14.7B
$10.2M 0.13%
29,330
+2,480
+9% +$817K
AMD icon
184
Advanced Micro Devices
AMD
$851B
$10.1M 0.13%
397,271
-130,935
-25% -$2.97M
MNST icon
185
Monster Beverage
MNST
$91.4B
$10.1M 0.13%
369,996
-167,546
-31% -$4.78M
AZUL
186
DELISTED
Azul
AZUL
$10M 0.13%
344,000
-157,000
-31% -$4.69M
ADP icon
187
Automatic Data Processing
ADP
$100B
$10M 0.13%
62,810
-27,595
-31% -$4.01M
FOLD
188
DELISTED
Amicus Therapeutics
FOLD
$10M 0.13%
736,000
+140,000
+23% +$1.71M
EIDX
189
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$9.97M 0.13%
425,000
+280,000
+193% +$4.49M
FITB
190
Fifth Third Bancorp
FITB
$52B
$9.96M 0.13%
394,965
-2,836
-0.7% -$75.5K
MRO
191
DELISTED
Marathon Oil Corporation
MRO
$9.91M 0.13%
593,136
+265,566
+81% +$4.34M
AWK icon
192
American Water Works
AWK
$26.3B
$9.87M 0.13%
94,652
+13,435
+17% +$1.32M
SYF icon
193
Synchrony
SYF
$23.7B
$9.85M 0.13%
308,626
-47,315
-13% -$1.42M
OXY icon
194
Occidental Petroleum
OXY
$57B
$9.81M 0.13%
148,199
+56,800
+62% +$3.74M
KMI icon
195
Kinder Morgan
KMI
$73.1B
$9.79M 0.13%
489,106
-22,626
-4% -$422K
VLO icon
196
Valero Energy
VLO
$89.8B
$9.76M 0.12%
115,056
+14,443
+14% +$1.19M
UHS icon
197
Universal Health Services
UHS
$9.43B
$9.7M 0.12%
72,474
-17,153
-19% -$2.26M
FANG icon
198
Diamondback Energy
FANG
$57.6B
$9.53M 0.12%
93,862
+85,248
+990% +$8.73M
HALO icon
199
Halozyme
HALO
$9.72B
$9.51M 0.12%
590,579
+313,579
+113% +$5.08M
UNM icon
200
Unum
UNM
$13.8B
$9.51M 0.12%
280,941
+6,569
+2% +$229K
6 7
8
9 10

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2019 Portfolio in Review

As of Q1 2019, Candriam SCA held 869 positions worth $7.82B, up 20% from $6.51B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Candriam SCA's Q1 2019 filing shows 65 new, 350 increased, 240 reduced and 81 closed positions. Its largest new stake was Baozun: 640,000 shares worth $26.6M. The largest sale was Celgene Corp, an estimated $75.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2019 buy was Baozun: 640,000 shares worth $26.6M.
  • Candriam SCA added most to Merck in Q1 2019, an estimated $43.7M increase.
  • Candriam SCA's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $75.2M.
  • Candriam SCA fully exited Loxo Oncology, Inc in Q1 2019, selling an estimated $28.1M.
  • Candriam SCA's ten largest holdings make up 19% of its $7.82B portfolio in Q1 2019.
  • Candriam SCA opened 65 new positions and closed 81 in Q1 2019.
  • Candriam SCA's portfolio value rose 20% quarter-over-quarter to $7.82B.

Based on Candriam SCA's 13F filing for Q1 2019, filed 2 May 2019.